UiPath, Inc.(PATH)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
PATH | 7.00 B | 20.04x | 13.40% | 21.03% | $0.67 | 20.03% | 0.04x | 0.00% | $19.84 | $9.20 |
FTNT | 125.41 B | 60.40x | 25.60% | 28.17% | $2.83 | 117.44% | 0.36x | 0.00% | $197.13 | $73.55 |
ZS | 34.98 B | - | 24.90% | -1.89% | -$0.39 | -2.87% | 0.72x | 0.00% | $336.99 | $114.62 |
RBRK | 18.44 B | - | 37.90% | -16.50% | -$1.27 | - | - | 0.00% | $127.90 | $42.25 |
Peer Valuation & Performance Analysis
Peer group analysis for UiPath, Inc. (PATH) compared to its primary competitors (including FTNT, ZS, RBRK) reveals distinct metrics. PATH trades at a valuation premium compared to its competitors, with a P/E ratio of 20.0x versus the peer average of -193.3x (representing a -110% premium). This indicates that the market expects superior growth or commands a quality premium for PATH. In terms of growth, PATH's revenue growth of 13.4% lags behind the peer average of 29.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 21.0% compared to the peer average of 3.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• PATH ranks #1 in P/E ratio, #4 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $13.12 | $13.61 | $13.12 | $13.43 | 32,842,893 | +2.36% |
| 2026-10-19 | $12.85 | $13.22 | $12.85 | $13.12 | 22,142,300 | +2.10% |
| 2026-10-16 | $13.82 | $14.00 | $12.73 | $12.85 | 29,329,200 | -6.27% |
| 2026-10-15 | $12.97 | $13.71 | $12.93 | $13.71 | 32,127,200 | +4.98% |
| 2026-10-14 | $13.17 | $13.30 | $12.91 | $13.06 | 23,290,100 | -1.43% |
| 2026-10-13 | $13.29 | $13.76 | $13.23 | $13.25 | 26,233,700 | -0.53% |
| 2026-10-12 | $13.64 | $13.82 | $13.11 | $13.32 | 23,436,900 | -1.19% |
| 2026-10-09 | $13.38 | $13.58 | $13.19 | $13.48 | 25,611,300 | +1.74% |
| 2026-10-08 | $13.08 | $13.38 | $12.96 | $13.25 | 34,325,000 | +1.38% |
| 2026-10-07 | $13.13 | $13.21 | $12.94 | $13.07 | 22,777,500 | -0.23% |
| 2026-10-06 | $13.22 | $13.35 | $12.94 | $13.10 | 18,203,500 | -0.46% |
| 2026-10-05 | $13.12 | $13.25 | $12.81 | $13.16 | 29,536,200 | +0.30% |
| 2026-10-02 | $13.41 | $13.42 | $13.02 | $13.12 | 19,709,700 | -1.50% |
| 2026-10-01 | $13.07 | $13.45 | $12.94 | $13.32 | 42,708,200 | +3.74% |
| 2026-09-30 | $12.32 | $13.00 | $12.32 | $12.84 | 42,518,700 | +4.22% |
Explore More Analysis for PATH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.